Novel cardiovascular therapeutics and the risk of financial toxicity
Nat Rev Cardiol
.
2024 Mar 14.
doi: 10.1038/s41569-024-01010-4.
Online ahead of print.
Authors
Alexander H Gunn
1
,
Akshay Pendyal
2
Affiliations
1
Department of Internal Medicine, Duke University School of Medicine, Durham, NC, USA. alexander.gunn@duke.edu.
2
Division of Cardiology, Duke University School of Medicine, Durham, NC, USA.
PMID:
38485769
DOI:
10.1038/s41569-024-01010-4
No abstract available